Goldstein Stuart L
Department of Pediatrics, Baylor College of Medicine, Texas 77030, USA.
Pediatr Nephrol. 2004 Jan;19(1):1-5. doi: 10.1007/s00467-003-1368-x. Epub 2003 Nov 22.
Measurement of dialysis adequacy relies on an assessment of small molecule clearance during the dialysis procedure. However, recent adult studies (HEMO and ADEMEX) that pushed clearance to maximally achievable levels within practical constraints of thrice-weekly hemodialysis or four times daily continuous ambulatory peritoneal dialysis failed to demonstrate improvements in patient outcome above current guidelines. The relatively low incidence of pediatric compared with adult end-stage renal disease limits large-scale study of pediatric dialysis. Several single-center pediatric studies demonstrate a lack of association between small solute clearance alone and patient growth. The aim of the current article is to review the relevant pediatric and adult studies of small solute clearance and put them in the context of optimal dialysis provision. While small solute clearances do indeed matter, clearance is not all that matters. Our quest to provide optimal dialysis requires that we also focus our attention on patient nutritional status, increased dialysis delivery (daily/nocturnal hemodialysis), and adjunctive dialysis modalities (hemofiltration and renal tubular replacement therapy).
透析充分性的评估依赖于透析过程中小分子清除率的测定。然而,近期的成人研究(HEMO研究和ADEMEX研究)在每周三次血液透析或每日四次持续性非卧床腹膜透析的实际限制范围内,将清除率提升至可达到的最高水平,却未能证明患者预后比现行指南有改善。与成人终末期肾病相比,儿科终末期肾病的发病率相对较低,这限制了儿科透析的大规模研究。几项单中心儿科研究表明,仅小分子清除率与患儿生长之间缺乏关联。本文的目的是回顾关于小分子清除率的相关儿科和成人研究,并将其置于最佳透析治疗的背景下进行探讨。虽然小分子清除率确实很重要,但清除率并非唯一重要的因素。我们要提供最佳透析治疗,就需要同时关注患者的营养状况、增加透析频率(每日/夜间血液透析)以及辅助透析方式(血液滤过和肾小管替代疗法)。